NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.03M | 17.08M | 13.47M | 13.49M | 12.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.03M | 17.08M | 13.47M | 13.49M | 12.87M |
| Cost of Revenue | 12.97M | 13.70M | 10.94M | 10.90M | 10.51M |
| Gross Profit | 3.06M | 3.38M | 2.54M | 2.59M | 2.36M |
| SG&A Expenses | 2.30M | 2.18M | 1.80M | 1.96M | 1.83M |
| Depreciation & Amortization | 404.40K | 414.90K | 416.00K | 420.10K | 421.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.68M | 16.29M | 13.16M | 13.29M | 12.76M |
| Operating Income | 355.00K | 784.20K | 317.00K | 206.50K | 107.00K |
| Income Before Tax | 18.20K | 354.20K | -135.20K | -102.20K | -198.70K |
| Income Tax Expenses | 86.40K | 107.00K | 92.70K | 26.40K | 38.10K |
| Earnings from Continuing Operations | -68.20K | 247.20K | -227.80K | -128.60K | -236.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -42.80K | -60.70K | -59.90K | -46.40K | -57.20K |
| Net Income | -111.10K | 186.50K | -287.80K | -175.00K | -294.00K |
| EBIT | 355.00K | 784.20K | 317.00K | 206.50K | 107.00K |
| EBITDA | 759.40K | 1.20M | 733.00K | 388.10K | 528.60K |
| EPS Basic | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 56.45M | 56.57M | 56.22M | 56.40M | 56.39M |
| Average Diluted Shares Outstanding | 58.26M | 58.15M | 57.18M | 56.40M | 56.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |